Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World Data.
作者信息
Farrand Erica, Anstrom Kevin J, Bernard Gordon, Butte Atul J, Iribarren Carlos, Ley Brett, Martinez Fernando J, Collard Harold R
机构信息
1 Department of Medicine and.
2 Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
出版信息
Am J Respir Crit Care Med. 2019 May 1;199(9):1061-1065. doi: 10.1164/rccm.201807-1209PP.
PMID:30452876
Abstract
摘要
相似文献
1
Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World Data.弥合间质性肺疾病的证据差距。真实世界数据的前景。
Am J Respir Crit Care Med. 2019 May 1;199(9):1061-1065. doi: 10.1164/rccm.201807-1209PP.
2
Interstitial Lung Disease in Veterans: Leveraging Big Data to Bridge Evidence and Practice Gaps.退伍军人的间质性肺疾病：利用大数据弥合证据与实践差距
Ann Am Thorac Soc. 2023 Apr;20(4):504-507. doi: 10.1513/AnnalsATS.202211-942PS.
3
The quality of research with real-world evidence.具有真实世界证据的研究质量。
Colomb Med (Cali). 2019 Sep 30;50(3):140-141. doi: 10.25100/cm.v50i3.4259.
4
Gender equity in interstitial lung disease.间质性肺疾病中的性别平等。
Lancet Respir Med. 2020 Sep;8(9):842-843. doi: 10.1016/S2213-2600(20)30310-6. Epub 2020 Jul 17.
5
The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration.欧洲儿童间质性肺疾病研究协作组（ChILDEU）欧洲呼吸学会临床研究协作组
Eur Respir J. 2018 Dec 6;52(6). doi: 10.1183/13993003.01855-2018. Print 2018 Dec.
6
Hospitalizations as Clinical Trials Endpoint in Interstitial Lung Disease: Are We There Yet?住院治疗作为间质性肺疾病临床试验的终点：我们做到了吗？
Am J Respir Crit Care Med. 2024 Sep 15;210(6):708-709. doi: 10.1164/rccm.202401-0203ED.
7
Clinical and research innovations in childhood interstitial lung disease (chILD).儿童间质性肺疾病（chILD）的临床与研究创新
Pediatr Pulmonol. 2024 Sep;59(9):2233-2235. doi: 10.1002/ppul.27025. Epub 2024 Apr 23.
8
Improving Reporting Quality in Ophthalmologic Observational Studies That Use Big Data: The Case of Retinal Detachment Associated With Fluoroquinolone Use.提高使用大数据的眼科观察性研究报告质量：以氟喹诺酮类药物使用相关视网膜脱离为例
JAMA Ophthalmol. 2018 Jun 1;136(6):611-612. doi: 10.1001/jamaophthalmol.2018.0987.
9
2008 British guidelines on the management of interstitial lung diseases. What are the key new messages for clinical practice?《2008年英国间质性肺疾病管理指南》。对临床实践而言，关键的新信息有哪些？
Pol Arch Med Wewn. 2009 Mar;119(3):112-4.
10
Interstitial lung disease points to consider for clinical trials in systemic sclerosis.系统性硬化症临床试验中需考虑的间质性肺疾病要点。
Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v27-v32. doi: 10.1093/rheumatology/kex203.
引用本文的文献
1
[Respiratory Disease in the Era of Big Data].[大数据时代的呼吸系统疾病]
Open Respir Arch. 2020 Oct-Dec;2(4):284-288. doi: 10.1016/j.opresp.2020.07.003. Epub 2020 Sep 10.
2
Walking the path of treatable traits in interstitial lung diseases.在间质性肺疾病中探寻可治疗的特征。
Respir Res. 2023 Oct 24;24(1):251. doi: 10.1186/s12931-023-02554-8.
3
Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective database.澳大拉西亚间质性肺病登记处（AILDR）：一个跨国前瞻性数据库的目标、设计和原理。
BMC Pulm Med. 2020 Oct 2;20(1):257. doi: 10.1186/s12890-020-01297-2.
Zotero 插件